Drug Development and Approval Process

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/33

flashcard set

Earn XP

Description and Tags

These flashcards cover key vocabulary terms and concepts associated with drug development and the approval process, highlighting important phases, testing methods, and regulatory classifications.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

34 Terms

1
New cards

In Vitro

Testing done in a controlled environment outside of a living organism, typically in a test tube.

2
New cards

High Throughput Screening

An automated process that allows the testing of many samples simultaneously to determine biological activity.

3
New cards

Phase I Trials

Initial testing phase for drugs involving healthy volunteers to assess safety and metabolism.

4
New cards

Phase II Trials

Testing phase where the drug is administered to patients who may benefit to evaluate its efficacy and monitor side effects.

5
New cards

Phase III Trials

Large-scale testing of a drug's effectiveness and long-term side effects conducted on thousands of patients.

6
New cards

Double Blind Study

A clinical trial design where neither the participants nor the researchers know who receives the treatment or the placebo.

7
New cards

Teratogens

Substances that cause developmental abnormalities in the fetus, increasing the risk of birth defects.

8
New cards

Drug Schedule System

Classification system by the DEA that ranks drugs based on their potential for abuse, from Schedule I (highest) to Schedule V (lowest).

9
New cards

Off-Label Use

Prescribing a drug for a purpose other than what it was originally approved for.

10
New cards

Patent Thicket

A situation where numerous overlapping patents cover various aspects of a drug, extending market exclusivity for the manufacturer.

11
New cards

Evergreening

The practice of extending patent protection on a drug by making slight modifications or introducing new formulations.

12
New cards

Idiosyncratic Effects

Unusual reactions to drugs that occur in a small number of individuals, often not predictable based on known effects.

13
New cards

Category A Drugs

Drugs deemed safe for use in pregnancy, with well-controlled studies showing no significant risk.

14
New cards

Category X Drugs

Drugs considered to have a high risk of causing birth defects and should not be used in pregnant women.

15
New cards

What is In Vitro testing?

Testing done in a controlled environment outside of a living organism, typically in a test tube.

16
New cards

What does High Throughput Screening refer to?

An automated process that allows the testing of many samples simultaneously to determine biological activity.

17
New cards

What occurs during Phase I Trials?

Initial testing phase for drugs involving healthy volunteers to assess safety and metabolism.

18
New cards

What is the purpose of Phase II Trials?

Testing phase where the drug is administered to patients who may benefit to evaluate its efficacy and monitor side effects.

19
New cards

What characterizes Phase III Trials?

Large-scale testing of a drug's effectiveness and long-term side effects conducted on thousands of patients.

20
New cards

What is a Double Blind Study?

A clinical trial design where neither the participants nor the researchers know who receives the treatment or the placebo.

21
New cards

What are Teratogens?

Substances that cause developmental abnormalities in the fetus, increasing the risk of birth defects.

22
New cards

What is the Drug Schedule System?

Classification system by the DEA that ranks drugs based on their potential for abuse, from Schedule I (highest) to Schedule V (lowest).

23
New cards

What does Off-Label Use mean?

Prescribing a drug for a purpose other than what it was originally approved for.

24
New cards

What is a Patent Thicket?

A situation where numerous overlapping patents cover various aspects of a drug, extending market exclusivity for the manufacturer.

25
New cards

In Vitro testing is typically done in and is conducted outside of a living organism.

a controlled environment

26
New cards

High Throughput Screening allows the testing of many samples to determine biological activity.

simultaneously

27
New cards

Phase I Trials involve volunteers to assess the safety and metabolism of a drug.

healthy

28
New cards

Teratogens are substances that increase the risk of by causing developmental abnormalities in the fetus.

birth defects

29
New cards

The Drug Schedule System ranks drugs based on their potential for , with Schedule I being the highest.

abuse

30
New cards

In Vitro testing is typically done in and is conducted outside of a living organism.

a controlled environment

31
New cards

High Throughput Screening allows the testing of many samples to determine biological activity.

simultaneously

32
New cards

Phase I Trials involve volunteers to assess the safety and metabolism of a drug.

healthy

33
New cards

Teratogens are substances that increase the risk of by causing developmental abnormalities in the fetus.

birth defects

34
New cards

The Drug Schedule System ranks drugs based on their potential for , with Schedule I being the highest.

abuse